In this episode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including the judicial activity surrounding Mifepristone, a medical abortion drug, and the recent announcement of Kaiser’s acquisition of Geisinger to launch Risant Health.  

Podcast Tags: healthcare, healthcare news, health plans, life sciences, health policy, public health, mergers and acquisitions, FDA 

Source Links: 

• Texas judge halts FDA approval of abortion pill 
• Supreme Court preserves access to key abortion drug as appeal proceeds   
• Supreme Court Delays Decision on Abortion Pill, Preserving Access for Now   
• Generic abortion pill manufacturer sues FDA in effort to preserve access   
• Supreme Court Ensures, for Now, Broad Access to Abortion Pill   
• 6 Ways the Mifepristone Rulings May Impact Future FDA Approvals  
• Kaiser Permanente to Acquire Geisinger   
• Kaiser Permanente and Geisinger come together to launch Risant Health  
• Kaiser Permanente: Commitments and Impact 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector 

[email protected] 

Ryan Hummel, Executive and Head of Provider Sector 

[email protected] 

Jen Burke, Healthcare Industry Strategist 

[email protected]